Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001837194 | SCV002097678 | likely pathogenic | Kleefstra syndrome 1 | 2020-05-29 | criteria provided, single submitter | clinical testing | The inherited heterozygous 53 kb deletion in EHMT is absent from the gnomAD SVs (v2) database indicating it is an extremely rare allele in the general population. This deletion removes the exon-2 (2/27, comprised of 64 nucleotides) of EHMT1 gene causing a shift in the wildtype translational reading frame and is predicted to result in loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Loss of function variants in the EHMT1 gene are known to be pathogenic [PMID: 16826528; PMID: 20945554]. Based on the current evidence, this inherited 53 kb deletion involving exon-2 of the EHMT1gene is assessed as likely pathogenic. |